About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | China Betaferon Adherence, Coping and Nurse Support Study

China Betaferon Adherence, Coping and Nurse Support Study

NCT01436838·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Bayer

Age

18–75

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Relapsing-remitting multiple scelrosis (RRMS) and secondary progressive multiple sclerosis (SPMS) patients
Having Betaferon treatment, including patients who are
* First time using; or
* Re-staring; or
* Switching from other diseases modifying drugs (DMDs)

You may not be if

Known or newly identified contraindication for administration of Betaferon according to Summary of Product Characteristic (SmPC).

The record

StatusCompleted

PhaseNo phase

Taking part110

StartedMar 2012

UpdatedSep 5, 2016

Conditions

Multiple Sclerosis, Chronic Progressive

Where1

Many Locations, China